Correlation Between AbcamPLC and Albireo Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AbcamPLC and Albireo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbcamPLC and Albireo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AbcamPLC and Albireo Pharma, you can compare the effects of market volatilities on AbcamPLC and Albireo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbcamPLC with a short position of Albireo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbcamPLC and Albireo Pharma.

Diversification Opportunities for AbcamPLC and Albireo Pharma

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between AbcamPLC and Albireo is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding AbcamPLC and Albireo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Albireo Pharma and AbcamPLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbcamPLC are associated (or correlated) with Albireo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Albireo Pharma has no effect on the direction of AbcamPLC i.e., AbcamPLC and Albireo Pharma go up and down completely randomly.

Pair Corralation between AbcamPLC and Albireo Pharma

Given the investment horizon of 90 days AbcamPLC is expected to generate 5.51 times less return on investment than Albireo Pharma. But when comparing it to its historical volatility, AbcamPLC is 3.2 times less risky than Albireo Pharma. It trades about 0.07 of its potential returns per unit of risk. Albireo Pharma is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  1,811  in Albireo Pharma on December 19, 2023 and sell it today you would earn a total of  2,604  from holding Albireo Pharma or generate 143.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy36.42%
ValuesDaily Returns

AbcamPLC  vs.  Albireo Pharma

 Performance 
       Timeline  
AbcamPLC 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days AbcamPLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, AbcamPLC is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Albireo Pharma 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Albireo Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental drivers, Albireo Pharma is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

AbcamPLC and Albireo Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AbcamPLC and Albireo Pharma

The main advantage of trading using opposite AbcamPLC and Albireo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbcamPLC position performs unexpectedly, Albireo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Albireo Pharma will offset losses from the drop in Albireo Pharma's long position.
The idea behind AbcamPLC and Albireo Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance